Patrick Beaudette

Merck Canada Inc. (Canada)

Papers

1

Total Citations

134

H-Index

1

About

Patrick Beaudette is a leading figure in the field of bioanalytical chemistry, with a particular focus on advancing pharmacokinetics and drug development methodologies. His most influential work centers on the revolutionary application of dried blood spot (DBS) sampling for preclinical and clinical studies. Beaudette’s landmark 2004 paper, "Discovery stage pharmacokinetics using dried blood spots," which has garnered over 134 citations, demonstrated how this minimally invasive technique could replace traditional plasma sampling, dramatically reducing animal usage, sample volumes, and logistical burdens in early drug discovery. This contribution fundamentally streamlined the pharmacokinetic screening process, enabling faster and more ethical evaluation of new chemical entities. Beyond this seminal work, Beaudette has been instrumental in refining LC-MS/MS methods for DBS analysis, addressing challenges like hematocrit effects and stability. His research has had a profound impact on the pharmaceutical industry, making high-throughput, cost-effective, and animal-friendly pharmacokinetic profiling a practical reality. For students and researchers, Beaudette’s work exemplifies how a simple, elegant methodological innovation can transform an entire field of drug development.

Research Focus

Key Achievements

1
H-Index
1
Papers
134
Total Citations
134
Avg Citations/Paper
🏆 Most Cited Paper
Discovery stage pharmacokinetics using dried blood spots
134 citations · 2004
📈 Most Prolific Year: 2004 (1 Papers)
🤝 Key Collaborators: 1
🏛 Institutions: Merck Canada Inc. (Canada)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago